As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current pharmaceutical design

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2174/1381612023396744PMID 11812250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benzodiazepines, memory and mood: a review

  2006cited by this paper
• Cognitive-Behavioral Therapy for Panic: Effectiveness and Limitations

  2004cited by this paper
• Drug deprivation and reinforcement by diazepam in a dependent population

  2004cited by this paper
• Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal.

  2002cited by this paper
• Pain therapy following joint replacement.A randomized study of patient-controlled analgesia versus conventional pain therapy.

  1999cited by this paper
• Patient-controlled analgesia.

  1999cited by this paper
• Why do patients feel positive about patient‐controlled analgesia?

  1999cited by this paper
• Patient-Controlled Analgesia: An Efficient Therapeutic Tool in the Postoperative Setting

  1999cited by this paper
• Patient-Controlled Analgesia in Postoperative Cardiac Surgery

  1999cited by this paper
• Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?

  1998cited by this paper
• International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.

  1998cited by this paper
• Alprazolam-reinforced medication use in outpatients with anxiety.

  1997cited by this paper
• Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse

  1997cited by this paper
• The use of newer antidepressants for panic disorder.

  1997cited by this paper
• Growing placebo response rate: the problem in recent therapeutic trials?

  1997cited by this paper
• Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course

  1996cited by this paper
• Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability.

  1996cited by this paper
• Benzodiazepines in primary health care: a survey of general practitioners prescribing patterns.

  1996cited by this paper
• Meta-analysis of cognitive-behavioral treatments for social phobia.

  1996cited by this paper
• Long-Term use of Benzodiazepines: Tolerance, Dependence and Clinical Problems in Anxiety and Mood Disorders

  1996cited by this paper
• Automaticity and the anxiety disorders.

  1995cited by this paper
• Social phobia: a pharmacologic treatment overview.

  1995cited by this paper
• Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures.

  1995cited by this paper
• Effect of psychological treatment on cognitive bias in generalized anxiety disorder.

  1995cited by this paper
• Benzodiazepine prescribing in general practice: dispelling some myths.

  1995cited by this paper
• Preferences for ethanol and diazepam in anxious individuals: an evaluation of the self-medication hypothesis

  1995cited by this paper
• International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders.

  1995cited by this paper
• Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.

  1995cited by this paper
• Dismantling cognitive-behavioral group therapy for social phobia.

  1995cited by this paper
• Clinical aspects of chronic use of alprazolam and lorazepam.

  1995cited by this paper
• Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia.

  1994cited by this paper
• Overview of current development in patient-controlled analgesia

  1994cited by this paper
• Medication therapy for social phobia.

  1994cited by this paper
• Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?

  1994cited by this paper
• Differential effects of lorazepam and oxazepam on priming

  1993cited by this paper
• A meta-analysis of treatments for panic disorder.

  1993cited by this paper
• Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia

  1993cited by this paper
• Predicting outcome after treatment for generalised anxiety disorder.

  1993cited by this paper
• The use of low-dose intranasal midazolam to treat panic disorder: a pilot study.

  1992cited by this paper
• Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines

  1991cited by this paper
• Long-term alprazolam use: abuse, dependence or treatment?

  1991cited by this paper
• Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

  1991cited by this paper
• Preference for Diazepam in Anxious Adults

  1990cited by this paper
• The benzodiazepines as drugs of abuse.

  1990cited by this paper
• Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.

  1990cited by this paper
• Behaviour Therapy and Benzodiazepines: Allies or Antagonists?

  1990cited by this paper
• Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.

  1990cited by this paper
• Treatment of Panic and Agoraphobia: An Integrative Review

  1990cited by this paper
• Treatment of postoperative pain: comparison between administration at fixed hours and 'on demand' with intramuscular analgesics.

  1989cited by this paper
• Generalization of therapeutic changes in agoraphobia: the role of perceived self-efficacy.

  1989cited by this paper
• Abuse liability of anxiolytics and sedative/hypnotics: methods assessing the likelihood of abuse.

  1989cited by this paper
• The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

  1989cited by this paper
• Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

  1988cited by this paper
• Anxiety and its disorders : the nature and treatment of anxiety and panic

  1988cited by this paper
• Effects of on-demand versus fixed-interval schedules in the treatment of chronic pain with analgesic compounds.

  1987cited by this paper
• Abuse liability of benzodiazepines.

  1987cited by this paper
• Lack of preference for diazepam in anxious volunteers.

  1986cited by this paper
• Colour naming of phobia-related words.

  1986cited by this paper
• Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.

  1986cited by this paper
• Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.

  1986cited by this paper
• Anxiety sensitivity, anxiety frequency and the prediction of fearfulness.

  1986cited by this paper
• Changes in popular attitudes and beliefs about tranquilizers. 1970-1979.

  1986cited by this paper
• Selective processing of threat cues in anxiety states.

  1985cited by this paper
• Tolerance to the behavioral actions of benzodiazepines.

  1985cited by this paper
• Exposure as a treatment for social phobia: some instructive difficulties.

  1985cited by this paper
• Effects of Anxiolytic Drugs on the Partial Reinforcement Extinction Effect in Runway and Skinner Box

  1984cited by this paper
• Agoraphobia--a safety-signal perspective.

  1984cited by this paper
• Prevalence and correlates of the long‐term regular use of anxiolytics

  1984cited by this paper
• Long-term diazepam therapy and clinical outcome.

  1983cited by this paper
• Drug therapy. Current status of benzodiazepines.

  1983cited by this paper
• The psychology of physical symptoms

  1982cited by this paper
• The effects of psychological therapy

  1980cited by this paper
• Tryptophan-5-hydroxylase: function and control.

  1974cited by this paper
• Diazepam on demand. Drug-seeking behavior in psychiatric inpatients.

  1974cited by this paper
• Sodium amobarbital and effects of frustrative nonreward.

  1969cited by this paper

• Benzos (as) needed: research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices

  2025cites this paper
• Cannabis use regimens in trauma-exposed individuals: Associations with cannabis use quantity and frequency.

  2024cites this paper
• Benzodiazepine‐induced photosensitivity reactions: A compilation of cases from literature review with Naranjo causality assessment

  2021cites this paper
• Psychotropic Pro Re Nata (Prn) Medications: A Critical Comparative Inquiry

  2019cites this paper
• [Effect of Digital Labels on Electronic Medical Records for Reducing the Use of Benzodiazepine Receptor Agonists].

  2019cites this paper
• Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients.

  2018cites this paper
• Regulation of GABAA receptors by prolonged exposure to endogenous and exogenous ligands

  2018cites this paper
• O consumo de benzodiazepinas e os efeitos das intervenções psicológicas no contexto dos cuidados de saúde primários.

  2013cites this paper
• The South African Society of Psychiatrists (SASOP) treatment guidelines for psychiatric disorders

  2013cites this paper
• Benzoxepin derivatives: design, synthesis, and pharmacological evaluation with sedative–hypnotic effect

  2012influential citation
• A Practitioner’s Guide to Prescribing Clonazepam for Adults with Intellectual Disabilities

  2012cites this paper
• A Practitioner’s Guide to Prescribing Diazepam for Adults with Intellectual Disabilities

  2012cites this paper
• A Practitioner’s Guide to Prescribing Lorazepam for Adults with Intellectual Disabilities

  2012cites this paper
• The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients

  2011cites this paper
• Drug Misuse and Diversion in Adults Prescribed Anxiolytics and Sedatives

  2011cites this paper
• SUBSTANCE USE AND PSYCHIATRIC CHARACTERISTICS OF PRESCRIPTION OPIOID USERS IN A LOW-THRESHOLD METHADONE MAINTENANCE TREATMENT PROGRAM IN NOVA SCOTIA

  2011cites this paper
• Alcohol consumption among Canadians taking benzodiazepines and related drugs

  2009cites this paper
• Cognitive‐behavior therapy for Japanese patients with panic disorder: Acute phase and one‐year follow‐up results

  2008cites this paper
• A Self-Help Handout for Benzodiazepine Discontinuation Using Cognitive Behavioral Therapy

  2008cites this paper
• Metabolic mapping of rat brain activity associated with conditioned fear extinction and renewal, and improvement of extinction memory by the metabolic enhancer methylene blue

  2006cites this paper
• Panic Disorder and Smoking

  2006cites this paper
• The use of benzodiazepines in palliative care

  2006cites this paper
• History repeats itself: pharmacodynamic trends in the treatment of anxiety disorders.

  2005cites this paper
• Animal models of depressive illness: the importance of chronic drug treatment.

  2005cites this paper
• Effects of Additional Oxazepam in Long-Term Users of Oxazepam

  2005cites this paper
• Benzodiazepine Use Associated with Decreased Memory for Psychoeducation Material in Cognitive Behavioral Therapy for Panic Disorder

  2004cites this paper
• Practice to research: use of benzodiazepines as adjunctive medications

  2004cites this paper
• Delta opioid peptides derived from plant proteins.

  2003cites this paper
• Medication dependence and anxiety

  2003cites this paper
• Benzodiazepine discontinuation treatment in outpatients with complicated dependence

  2003cites this paper
• Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia.

  2002cites this paper